Allmed Medical Products(002950) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

002950 Allmed Medical Products

Watchlist

9.45
+0.43+4.77%

Trading Mar 17 10:41 CST

5.98BMarket Cap26.54P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Allmed Medical Products (002950.SZ): Has not yet repurchased company shares.
Gelonghui, February 5th丨Allmed Medical Products (002950.SZ) announced that as of January 31, 2025, the company has not repurchased its shares through a special securities account for repurchase via centralized bidding.
Gelonghui FinanceFeb 5 05:27 ET
Ogilvy Healthcare: 2024 Annual Results Forecast
SZSIJan 24 11:00 ET · Announcements
Allmed Medical ProductsLtd's (SZSE:002950) Earnings Trajectory Could Turn Positive as the Stock Lifts 8.0% This Past Week
Simply Wall StJan 14 17:15 ET
Jinhai Cui Allmed Medical Products Co.,Ltd's (SZSE:002950) CEO Is the Most Bullish Insider, and Their Stock Value Gained 14%last Week
Simply Wall StNov 21, 2024 19:59 ET
allmed medical products (002950.SZ) has repurchased 1.9771% of shares, costing approximately 97.88 million yuan.
China Fortune Financial and Economics APP News, allmed medical products (002950.SZ) announced that, as of October 31, 2024, the company's total...
Zhitong FinanceNov 1, 2024 05:26 ET
Ogilvy Healthcare: Third Quarter 2024 Report
SZSIOct 30, 2024 12:00 ET · Announcements

Comments

Moomoo AI

Feb 28, 2024 07:50

Allmed Medical ProductsLtd's declining ROCE and revenue despite increased capital deployment is concerning. The reduction in current liabilities, while reducing some business risk, may have made the business less efficient at generating ROCE. Considering these trends, exploring other investment options may be advisable.

Be Wary Of Allmed Medical ProductsLtd (SZSE:002950) And Its Returns On Capital

Moomoo AI

Feb 3, 2024 08:25

Investors may believe Allmed Medical Products Co.,Ltd's earnings growth will underperform the broader market, contributing to its low P/E ratio. The company's shrinking medium-term earnings could continue to hinder the share price.

The Market Doesn't Like What It Sees From Allmed Medical Products Co.,Ltd's (SZSE:002950) Earnings Yet As Shares Tumble 26%

Moomoo AI

Jan 19, 2024 12:11

The company's mediocre ROE and flat net income growth are unimpressive. Its decision to pay dividends despite stagnant earnings growth may impact its financial performance. High profit retention and low return rate could be hampering earnings growth.